Urinary α1-Antichymotrypsin: A Biomarker of Prion Infection

The occurrence of blood-borne prion transmission incidents calls for identification of potential prion carriers. However, current methods for intravital diagnosis of prion disease rely on invasive tissue biopsies and are unsuitable for large-scale screening. Sensitive biomarkers may help meeting this need. Here we scanned the genome for transcripts elevated upon prion infection and encoding secreted proteins. We found that α1-antichymotrypsin (α1-ACT) was highly upregulated in brains of scrapie-infected mice. Furthermore, α1-ACT levels were dramatically increased in urine of patients suffering from sporadic Creutzfeldt-Jakob disease, and increased progressively throughout the disease. Increased α1-ACT excretion was also found in cases of natural prion disease of animals. Therefore measurement of urinary α1-ACT levels may be useful for monitoring the efficacy of therapeutic regimens for prion disease, and possibly also for deferring blood and organ donors that may be at risk of transmitting prion infections.

[1]  K. Hess,et al.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.

[2]  P. Brown,et al.  Iatrogenic Creutzfeldt–Jakob disease , 2006, Neurology.

[3]  R. Gabizon,et al.  Prion urine comprises a glycosaminoglycan-light chain IgG complex that can be stained by Congo red. , 2006, Journal of virological methods.

[4]  P. Righetti,et al.  Searching for markers of Creutzfeldt‐Jakob disease in cerebrospinal fluid by two‐dimensional mapping , 2006, Proteomics.

[5]  Justin C McArthur,et al.  Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis , 2006, Annals of neurology.

[6]  G. J. Raymond,et al.  The most infectious prion protein particles , 2005, Nature.

[7]  J. Castilla,et al.  Detection of prions in blood , 2005, Nature Medicine.

[8]  R. Gabizon,et al.  Characterization of light chain immunoglobulin in urine from animals and humans infected with prion diseases , 2005, Journal of Neuroimmunology.

[9]  S. Prusiner,et al.  Immunoglobulins in Urine of Hamsters with Scrapie* , 2004, Journal of Biological Chemistry.

[10]  J. Fazakerley,et al.  Identification of up‐regulated genes by array analysis in scrapie‐infected mouse brains , 2004, Neuropathology and applied neurobiology.

[11]  Mark Head,et al.  Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .

[12]  Jean-Charles Sanchez,et al.  Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt‐Jakob disease , 2004, Proteomics.

[13]  J. MacKenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[14]  A. Aguzzi,et al.  Mammalian Prion Biology One Century of Evolving Concepts , 2004, Cell.

[15]  F. Heppner,et al.  Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion , 2003, Nature.

[16]  K. Blennow,et al.  Inflammatory Markers in Matched Plasma and Cerebrospinal Fluid from Patients with Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[17]  L. Manuelidis,et al.  Unique inflammatory RNA profiles of microglia in Creutzfeldt–Jakob disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Wisniewski,et al.  Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment , 2003, Annals of neurology.

[19]  J. Levy,et al.  Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. , 2002, Diabetes care.

[20]  S. DeKosky,et al.  Distribution of plasma α1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls , 2002, Neurobiology of Aging.

[21]  Cheng Li,et al.  Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application , 2001, Genome Biology.

[22]  A. Aguzzi,et al.  Efficient Lymphoreticular Prion Propagation Requires PrPc in Stromal and Hematopoietic Cells , 2001, Journal of Virology.

[23]  Z. Janka,et al.  Serum and cerebrospinal fluid cystatin C levels in vascular and Alzheimer's dementia. , 2000, Acta neurologica Scandinavica.

[24]  G. Miele,et al.  Elimination of false positives generated through PCR re-amplification of differential display cDNA. , 1998, BioTechniques.

[25]  C. Gibbs,et al.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.

[26]  H. Wiśniewski,et al.  α1-Antichymotrypsin and IL-1β are not increased in CSF or serum in Alzheimer's disease , 1994, Neurobiology of Aging.

[27]  K. Kato,et al.  High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[28]  A. Haase,et al.  Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes , 1991, Journal of virology.

[29]  M. Dinauer,et al.  Library subtraction of in vitro cDNA libraries to identify differentially expressed genes in scrapie infection. , 1990, Nucleic acids research.

[30]  H. Potter,et al.  α 1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α 1-antichymotrypsin , 1990, Neurobiology of Aging.

[31]  B. Seed,et al.  Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Selkoe,et al.  Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease , 1988, Cell.

[33]  R. Purcell,et al.  SEROLOGICAL RESPONSE TO THE HEPATITIS DELTA VIRUS IN HEPATITIS D , 1987, The Lancet.

[34]  S. Prusiner,et al.  A protease-resistant protein is a structural component of the Scrapie prion , 1983, Cell.

[35]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[36]  D. Gajdusek,et al.  DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.

[37]  H. Fraser,et al.  Pathogenesis of Scrapie in the Mouse: the Role of the Spleen , 1970, Nature.

[38]  D. Cucinotta,et al.  Acute Phase Reactant α1Antichymotrypsin Is Increased in Cerebrospinal Fluid and Serum of Patients with Probable Alzheimer Disease , 1995, Alzheimer disease and associated disorders.

[39]  H. Wiśniewski,et al.  Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease. , 1994, Neurobiology of aging.

[40]  H. Potter,et al.  Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. , 1990, Neurobiology of aging.

[41]  A. Trevisan.  Concentration adjustment of spot samples in analysis of urinary xenobiotic metabolites. , 1990, American journal of industrial medicine.

[42]  T. Nikolaus,et al.  Research Letters , 2022 .